Cell-free DNA (cfDNA) in the circulating blood plasma of patients with cancer contains
tumour-derived DNA sequences that can serve as biomarkers for guiding therapy, for the …

In the current era of precision medicine, the identification of genomic alterations has
revolutionised the management of patients with solid tumours. Recent advances in the …

This is a review of the current state of molecular profiling in gastrointestinal (GI) cancers and
what to expect from this evolving field in the future. Individualized medicine is moving from …

Overview Despite our modern perioperative therapies, many patients with gastrointestinal
cancer relapse after surgery. Novel strategies to identify and treat patients at high risk of …

A number of assays are now available to estimate the prognosis of early-stage colorectal
cancer, including multigene assays, the Immunoscore, and circulating tumor DNA (ctDNA) …